PerQdisc will be studied in degenerative disc disease patients, according to a Nov. 15 company news release. The device replaces a single nucleus pulposus between spinal discs and is an alternative to spinal fusion and disc replacement.
The trial is enrolling 72 patients across seven research centers in South America.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.